Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry

ABSTRACTAggregates are recognized as one of the most critical product-related impurities in monoclonal antibody (mAb)-based therapeutics due to their negative impact on the stability and safety of the drugs. So far, investigational efforts have primarily focused on understanding the causes and effec...

Full description

Bibliographic Details
Main Authors: Jing Xu, John E. Coughlin, Malgorzata Szyjka, Serene Jabary, Sonal Saluja, Zoran Sosic, Yunqiu Chen, Chong-Feng Xu
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:mAbs
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19420862.2024.2334783
_version_ 1797238968891211776
author Jing Xu
John E. Coughlin
Malgorzata Szyjka
Serene Jabary
Sonal Saluja
Zoran Sosic
Yunqiu Chen
Chong-Feng Xu
author_facet Jing Xu
John E. Coughlin
Malgorzata Szyjka
Serene Jabary
Sonal Saluja
Zoran Sosic
Yunqiu Chen
Chong-Feng Xu
author_sort Jing Xu
collection DOAJ
description ABSTRACTAggregates are recognized as one of the most critical product-related impurities in monoclonal antibody (mAb)-based therapeutics due to their negative impact on the stability and safety of the drugs. So far, investigational efforts have primarily focused on understanding the causes and effects of mAb self-aggregation, including both internal and external factors. In this study, we focused on understanding mAb stability in the presence of its monovalent fragment, formed through hinge cleavage and loss of one Fab unit (referred to as “Fab/c”), a commonly observed impurity during manufacturing and stability. The Fab/c fragments were generated using a limited IgdE digestion that specifically cleaves above the IgG1 mAb hinge region, followed by hydrophobic interaction chromatographic (HIC) enrichment. Two IgG1 mAbs containing different levels of Fab/c fragments were incubated under thermally accelerated conditions. A method based on size exclusion chromatography coupled with native mass spectrometry (SEC-UV-native MS) was developed and used to characterize the stability samples and identified the formation of heterogeneous dimers, including intact dimer, mAb-Fab/c dimer, Fab/c-Fab/c dimer, and mAb-Fab dimer. Quantitative analyses on the aggregation kinetics suggested that the impact of Fab/c fragment on the aggregation rate of individual dimer differs between a glycosylated mAb (mAb1) and a non-glycosylated mAb (mAb2). An additional study of deglycosylated mAb1 under 25°C accelerated stability conditions suggests no significant impact of the N-glycan on mAb1 total aggregation rate. This study also highlighted the power of SEC-UV-native MS method in the characterization of mAb samples with regard to separating, identifying, and quantifying mAb aggregates and fragments.
first_indexed 2024-04-24T17:44:05Z
format Article
id doaj.art-8a4dd72d29084788975e90ab944ead49
institution Directory Open Access Journal
issn 1942-0862
1942-0870
language English
last_indexed 2024-04-24T17:44:05Z
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series mAbs
spelling doaj.art-8a4dd72d29084788975e90ab944ead492024-03-27T16:47:26ZengTaylor & Francis GroupmAbs1942-08621942-08702024-12-0116110.1080/19420862.2024.2334783Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometryJing Xu0John E. Coughlin1Malgorzata Szyjka2Serene Jabary3Sonal Saluja4Zoran Sosic5Yunqiu Chen6Chong-Feng Xu7Analytical Development, Biogen, Cambridge, MA, USAProcess Biochemistry, Biogen, Cambridge, MA, USAAnalytical Biochemistry, Biogen, Cambridge, MA, USABiologics Product Development, Biogen, Cambridge, MA, USABiologics Product Development, Biogen, Cambridge, MA, USAAnalytical Development, Biogen, Cambridge, MA, USAAnalytical Development, Biogen, Cambridge, MA, USAAnalytical Development, Biogen, Cambridge, MA, USAABSTRACTAggregates are recognized as one of the most critical product-related impurities in monoclonal antibody (mAb)-based therapeutics due to their negative impact on the stability and safety of the drugs. So far, investigational efforts have primarily focused on understanding the causes and effects of mAb self-aggregation, including both internal and external factors. In this study, we focused on understanding mAb stability in the presence of its monovalent fragment, formed through hinge cleavage and loss of one Fab unit (referred to as “Fab/c”), a commonly observed impurity during manufacturing and stability. The Fab/c fragments were generated using a limited IgdE digestion that specifically cleaves above the IgG1 mAb hinge region, followed by hydrophobic interaction chromatographic (HIC) enrichment. Two IgG1 mAbs containing different levels of Fab/c fragments were incubated under thermally accelerated conditions. A method based on size exclusion chromatography coupled with native mass spectrometry (SEC-UV-native MS) was developed and used to characterize the stability samples and identified the formation of heterogeneous dimers, including intact dimer, mAb-Fab/c dimer, Fab/c-Fab/c dimer, and mAb-Fab dimer. Quantitative analyses on the aggregation kinetics suggested that the impact of Fab/c fragment on the aggregation rate of individual dimer differs between a glycosylated mAb (mAb1) and a non-glycosylated mAb (mAb2). An additional study of deglycosylated mAb1 under 25°C accelerated stability conditions suggests no significant impact of the N-glycan on mAb1 total aggregation rate. This study also highlighted the power of SEC-UV-native MS method in the characterization of mAb samples with regard to separating, identifying, and quantifying mAb aggregates and fragments.https://www.tandfonline.com/doi/10.1080/19420862.2024.2334783Aggregationaggregation ratefragmentsheterodimersmonoclonal antibodynative mass spectrometry
spellingShingle Jing Xu
John E. Coughlin
Malgorzata Szyjka
Serene Jabary
Sonal Saluja
Zoran Sosic
Yunqiu Chen
Chong-Feng Xu
Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry
mAbs
Aggregation
aggregation rate
fragments
heterodimers
monoclonal antibody
native mass spectrometry
title Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry
title_full Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry
title_fullStr Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry
title_full_unstemmed Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry
title_short Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry
title_sort evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry
topic Aggregation
aggregation rate
fragments
heterodimers
monoclonal antibody
native mass spectrometry
url https://www.tandfonline.com/doi/10.1080/19420862.2024.2334783
work_keys_str_mv AT jingxu evaluationoftheimpactofantibodyfragmentsonaggregationofintactmoleculesviasizeexclusionchromatographycoupledwithnativemassspectrometry
AT johnecoughlin evaluationoftheimpactofantibodyfragmentsonaggregationofintactmoleculesviasizeexclusionchromatographycoupledwithnativemassspectrometry
AT malgorzataszyjka evaluationoftheimpactofantibodyfragmentsonaggregationofintactmoleculesviasizeexclusionchromatographycoupledwithnativemassspectrometry
AT serenejabary evaluationoftheimpactofantibodyfragmentsonaggregationofintactmoleculesviasizeexclusionchromatographycoupledwithnativemassspectrometry
AT sonalsaluja evaluationoftheimpactofantibodyfragmentsonaggregationofintactmoleculesviasizeexclusionchromatographycoupledwithnativemassspectrometry
AT zoransosic evaluationoftheimpactofantibodyfragmentsonaggregationofintactmoleculesviasizeexclusionchromatographycoupledwithnativemassspectrometry
AT yunqiuchen evaluationoftheimpactofantibodyfragmentsonaggregationofintactmoleculesviasizeexclusionchromatographycoupledwithnativemassspectrometry
AT chongfengxu evaluationoftheimpactofantibodyfragmentsonaggregationofintactmoleculesviasizeexclusionchromatographycoupledwithnativemassspectrometry